A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia
Clinical trial NCT03697252 · COMPLETED
Trial details
- NCT number
- NCT03697252
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2019-09-04
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.